Type B3 Thymoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-06-09
Clinical Trial Update: Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines (Style Trial) [Phase 2]
Phase 2 trial evaluating sunitinib in patients with Type B3 thymoma or thymic carcinoma in second and later lines; status currently UNKNOWN.